THE MANAGEMENT OF THE PREGNANCY IN PREGNANT WOMEN INFECTED WITH THE PARVOVIRUS B19

Authors

  • V. F. Struk
  • I. I. Hudyvok

DOI:

https://doi.org/10.11603/24116-4944.2008.1.9509

Keywords:

pregnancy, parvovirus B19

Abstract

It was mode a comparative research of the management of the pregnancy in women, infected with the parvovirus B19, with general and proposed by the authors’sheme. The observation and the treatment held with the nextsheme: 1) in the first trimester of the pregnancy - ultrasonography and research of hormones of blood (human chorionic gonadotropin-? and progesteron)with the aim of the carly diagnosis of complications of the pregnancy which very often appear in parvovirial infection (the threat of the misbirth, spontaneous misbirth, dead pregnancy) every 2 weeks, less 12 weeks from the moment of the diagnosis of parvovirial infection, antihomotoxic preparations engystol and placenta compositum; 2) in the second and third trimester of the pregnancy - ultrasonography (doplerography)and the research of hormones of blood (freeestriol and placental lactogen) with the aim of the carly diagnosis of complications of the pregnancy with appear in parvovirial infection (placental insufficiency, distress of the fetus, dropsy of misbirth, dead fetus) and also the treatment of parvovirial infection was mode with antihomotoxic preparations engystol and placenta compositum in complex with the immunoglobulinum human normal pro injectionibus intravenosa with the aim of methodological recommendations TOH of Ukraine "The prophylaxis and treatment of tocologic and perinatal complications pregnant women with parvovirial infection". It is determined that the rate of tocologic and perinatal complications in the group, where pregnant women were observed in the sheme wtich is proposed by authors ,was realy (p<0,05) smaller than in the group, where researches held for general sheme.

References

1. Moiseenko R.O. Mother and child care - the duty of the state // Your health. - 2007. - No. 20 (847) .- Р. 2
2. Infections in obstetrics and gynecology / Ed. Makarova O.V., Aleshkina VA, SavchenkoT.N. - Moscow: MED-press-inform, 2007. – 464р.
3. Guseva O. I., Katkova N. Yu., Kachalina T. S., Dobrotina A. F., et al. Clinic, diagnostics and treatment of TORCH infections during pregnancy: educational and methodical manual. - Nizhny Novgorod: Publishing house of the National Academy of Agrarian Sciences, 2005. - 46 p.
4. Bhal R. S., Davies N. J., Westmoreland D., Jones A. Spontaneous resolution of non-immune hydrops fetalis secondary to transplacental parvovirus B19 infection // Ultrasound in Obstetrics and Gynecology. - 1996. - Vol. 7 (1) .- P 55-57.
5. Miyagawa S., Takahashi Y., Nagai A., Yamamoto Y. et al. Angioedema in a neonate with IgG antibodies to parvovirus B19following intrauterine parvovirus B19 infection // British Journal of Dermatology. - 2000. - Vol. 143 (2). - Р. 428-430.
6. Vafaie J., Schwartz R. A. Parvovirus B19 infections // International Journal of Dermatology. - 2004 - Vol. 43 (10) .- P. 747-749.

Published

2018-10-24

How to Cite

Struk, V. F., & Hudyvok, I. I. (2018). THE MANAGEMENT OF THE PREGNANCY IN PREGNANT WOMEN INFECTED WITH THE PARVOVIRUS B19. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1). https://doi.org/10.11603/24116-4944.2008.1.9509

Issue

Section

OBSTETRICS AND GYNECOLOGY